Syra Health (SYRA) Stock Price, News & Analysis

Company Overview

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.

Key Stats

• Today's Range: $0.08 to $0.10
• 50-Day Range: $0.05 to $0.20
• 52-Week Range: $0.03 to $1.71
• Volume: 9,503 shs
• Average Volume: 749,791 shs
• Market Capitalization: $1.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Syra Health Stock Analysis - MarketRank™

Syra Health scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Syra Health.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Syra Health is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Syra Health is -0.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Syra Health has a P/B Ratio of 0.16. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.40% of the float of Syra Health has been sold short.

Short Interest Ratio / Days to Cover

Syra Health has a short interest ratio ("days to cover") of 4.

Change versus previous month

Short interest in Syra Health has recently decreased by 7.23%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Syra Health does not currently pay a dividend.

Dividend Growth

Syra Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.40% of the float of Syra Health has been sold short.

Short Interest Ratio / Days to Cover

Syra Health has a short interest ratio ("days to cover") of 4.

Change versus previous month

Short interest in Syra Health has recently decreased by 7.23%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Syra Health this week, compared to 4 articles on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Syra Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

10.18% of the stock of Syra Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 4.75% of the stock of Syra Health is held by institutions.

SYRA Stock Analysis - Frequently Asked Questions

How have SYRA shares performed this year?

Syra Health's stock was trading at $0.4119 at the start of the year. Since then, SYRA shares have decreased by 75.5% and is now trading at $0.1009.
View the best growth stocks for 2025 here.

How were Syra Health's earnings last quarter?

Syra Health Corp. (NASDAQ:SYRA) posted its quarterly earnings results on Tuesday, March, 11th. The company reported ($0.05) EPS for the quarter. The business earned $2 million during the quarter, compared to analysts' expectations of $2.01 million. Syra Health had a negative trailing twelve-month return on equity of 131.94% and a negative net margin of 54.90%.
Read the conference call transcript.

When did Syra Health IPO?

Syra Health (SYRA) raised $7 million in an initial public offering on Friday, September 29th 2023. The company issued 1,600,000 shares at a price of $4.13 per share. Kingswood served as the underwriter for the IPO.

How do I buy shares of Syra Health?

Shares of SYRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Syra Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Syra Health investors own include American Airlines Group (AAL), Meta Platforms (META), PACCAR (PCAR), Super Micro Computer (SMCI), Arista Networks (ANET), Darden Restaurants (DRI) and Fabrinet (FN).

Company Calendar

• Last Earnings: 3/11/2025
• Today: 6/19/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Employment agencies
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:SYRA
• Previous Symbol: NASDAQ:SYRA
• CIK: 1922335
• Web: www.syrahealth.com
• Phone: 463-345-8950
• Fax: N/A
• Employees: 78
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.36)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.94 million
• Net Margins: -54.90%
• Pretax Margin: -54.90%
• Return on Equity: -131.94%
• Return on Assets: -99.19%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.63
• Quick Ratio: 4.63

Sales & Book Value

• Annual Sales: $7.98 million
• Price / Sales: 0.14
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.62 per share
• Price / Book: 0.16

Miscellaneous

• Outstanding Shares: 11,339,000
• Free Float: 10,156,000
• Market Cap: $1.14 million
• Optionable: Not Optionable
• Beta: 3.60